The Medical Letter on Drugs and Therapeutics is an indispensable tool that provides concise, critical, and authoritative drug information, giving you the expertise to make challenging treatment decisions.
All subscriptions include:
- Unlimited online and mobile access - fully searchable
- Up to 52 CME/MOC credits per year - accredited by ACCME, AAFP, AAPA, and ACPE
Critical appraisals of new drugs
Our "Drugs of Choice" articles that review all of the drugs for an indication, such as diabetes
- Comparative tables for quick reference
The Medical Letter provides:
- Evidence-based, peer-reviewed evaluations of new FDA-approved
drugs with conclusions reached by a consensus of experts
New information on previously approved drugs including pivotal
clinical trials, new indications, and safety warnings
Consensus recommendations for the preferred and alternative
treatments for common disorders
Comparative reviews of drugs for a given indication with particular
attention to clinical efficacy, adverse effects, drug interactions,
With over a quarter-million physician subscribers, as well as many of the leading academic
and clinical institutions in the world, TML is a trusted source for drug information.
The Medical Letter
Because the Source Matters.